Characterizing Formulations, Drug Targets and Viruses With SAXS and WAXS
White Paper Sep 18, 2020
Accelerating the stages of drug development with the use of robust testing methods ensures safe and stable products enter the market sooner, which is more important than ever given the current global pandemic. Both Small-Angle X-ray Scattering (SAXS) and Wide-Angle X-ray Scattering (WAXS) can provide drug developers with the ability to rapidly obtain information on structure and interactions of proteins in solution, protein complexes, antibodies and antigens as well as DNA/RNA.
Download this whitepaper to discover how these analytical techniques can facilitate research, development and quality control during drug development providing:
- Unique insights into protein shape, size and interactions
- Answers to molecular flexibility and conformational changes
- Relevant results using small sample volumes
Related White Papers
A common topic amongst biopharmaceutical companies is data quality
and data integrity; high data quality and integrity is critical to ensure patient safety and drug efficacy from research and development through to manufacturing. This whitepaper examines data integrity at every stage of the drug development process.